180 Life Sciences Corp. announced on May 7, 2024, Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer) the company effective the same date. Also effective on May 7, 2024, effective immediately after the resignation of Dr. Woody, the board of directors appointed Mr. Blair Jordan, a then member of the board of directors of the company, as interim chief executive officer and Principal Executive Officer of the company, to fill the vacancy left by Dr. Woody's resignation.

Upon such appointment, Mr. Jordan ceased being the Lead Independent director of the Company (which position is currently vacant), and ceased being a member of the Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee, and Strategy and Alternatives Committee of the Board of Directors.